A. Barbaud, Drug-induced contact dermatitis: an update and advice concerning the prescriptions of systemic drugs., REV FR ALLE, 39(4), 1999, pp. 301-310
Citations number
69
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
Drug contact dermatitis can induce a systemic cutaneous adverse drug reacti
on following systemic challenge with the drug. Clinical features of systemi
c contact allergy are various e.g. generalized eczema, Baboon syndrome, pom
pholyx, maculopapular rash... Systemic challenge with the drug responsible
can also induce reactivation of contact eczema (flare-up). Systemic contact
dermatitis has been described for example with corticosteroids, imidazoles
, anti-metabolites, heparin, aciclovir or propacetamol. Thimerosal-positive
patients, if sensitized to thiosalicylic acid (one of the sensitizing moie
ties of this preservative) have a high risk of develvoping a photosensitiza
tion to piroxicam. A review of the literature concerning contact dermatitis
due to drugs, cross-reactions between drugs with chemical similarities and
the risk of inducing systemic contact dermatitis with drugs is preserved.
Knowledge about the risk of systemic contact dermatitis due to the excipien
ts or the drug itself is important to keep in mind to advise he patients wh
o have previously developed drug-induced contact dermatitis.